Enveric Biosciences Inc
(ENVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 0 | 750 | 330 | 1,190 | 1,100 |
| Cost of Goods | 0 | 60 | 0 | 100 | 110 |
| Gross Profit | 0 | 680 | 330 | 1,080 | 990 |
| Operating Expenses | 50 | 490 | 670 | 1,270 | 1,250 |
| Operating Income | -50 | 260 | -340 | -80 | -150 |
| Interest Expense | 0 | 2 | 2 | 5 | 10 |
| Other Income | 0 | 542 | 2 | 5 | 10 |
| Pre-tax Income | -50 | 800 | -340 | -80 | -150 |
| Income Tax | 3 | 0 | 5 | -1 | 0 |
| Net Income Continuous | -53 | 800 | -345 | -79 | -150 |
| Net Income | $-50 | $800 | $-350 | $-80 | $-150 |
| EPS Basic Total Ops | -39,608.65 | 207,987.30 | -113,532.70 | -26,982.19 | -50,569.55 |
| EPS Basic Continuous Ops | -41,985.17 | 207,987.30 | -111,910.80 | -26,644.91 | -50,569.55 |
| EBITDA(a) | $-50 | $260 | $-310 | $-40 | $-100 |